BOOTHBAY FUND MANAGEMENT, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$35,000
-55.1%
10,965
-28.5%
0.00%
-87.5%
Q1 2019$78,000
-25.7%
15,333
-49.8%
0.01%
-46.7%
Q4 2018$105,000
+275.0%
30,562
+62.1%
0.02%
+36.4%
Q2 2016$28,000
+3.7%
18,8500.0%0.01%
+10.0%
Q1 2016$27,000
+28.6%
18,850
+48.8%
0.01%
+11.1%
Q4 2015$21,00012,6700.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders